Tauriga Sciences Inc (TAUG) 0.0040 $TAUG
Tauriga Sciences, Inc. Obtains Determination From OTC Markets Concerning OTCQB Listing Requirements
Marketwired - Thu Oct 08, 7:01AM CDT
Tauriga Sciences, Inc. (OTC PINK: TAUG) or ("Tauriga" or the "Company"
, a diversified life sciences company focused on building its existing technologies and evaluating potential acquisition candidates, has today announced that the Company has been granted additional time to regain compliance with OTCQB listing requirements. Specifically Tauriga has been notified by OTC Markets that it has until close of business January 27, 2016 ("extended deadline" to fully comply with the listing requirements that govern fully reporting U.S. companies listed on the OTCQB. By that date, the Company must become current with its delinquent filings ("filings" , post a new OTCQB Certification via www.otciq.com, and close at or above $.01 per share for 30 consecutive days. Currently shares of Tauriga are listed on the OTC Pink Limited Information Tier until it regains compliance with the above requirements.
Tauriga Sciences, Inc. Secures $180,000 USD in Non-Convertible Debt Financing From Singapore-Based Institutional Investor
Marketwired - Thu Oct 01, 10:45AM CDT
Tauriga Sciences, Inc. (OTC PINK: TAUG) or ("Tauriga" or the "Company" , a diversified life sciences company focused on building its existing technologies and evaluating potential acquisition candidates, has today announced the completion of $180,000 USD in Non-Convertible debt financing from Singapore-based institutional investor ALTERNATIVE STRATEGY PARTNERS PTE. LTD. ("ASP" . The debt carries a fixed interest rate per annum of 11.50% ("the Designated Rate" payable in full by December 23, 2015 ("the Maturity Date" . Both parties have discussed the possibility of amending terms, if necessary, under the assumption that both parties mutually agree to such amendment.
Tauriga Sciences Inc. Issues Shareholder Update on Status of Company and Future Strategic Plan
Marketwired - Fri Aug 14, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or the "Company" , a diversified life sciences company, is providing its shareholders with a comprehensive update on the status of the Company as well as it strategic plan for the future. The Company's Board of Directors ("Board" has met multiple times over the past weeks to address several important issues. The Company will continually issue press releases to update shareholders whenever practicable.
Tauriga Sciences, Inc. Appoints Mr. Thomas J. Graham as a Member of the Board of Directors
Marketwired - Wed Aug 05, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or the "Company" , a diversified life sciences company, today announced the appointment of Mr. Thomas J. Graham as the fourth member of the Company's Board of Directors ("Board" . The appointment is effective immediately and Mr. Graham will qualify as an "independent" under the rules of the Securities and Exchange Commission. In the future, Mr. Graham may also be appointed to certain committees of Board.
Tauriga Sciences Inc. Comments on the Status of Fiscal Year 2015 Form 10-K Filing
Marketwired - Fri Jul 31, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or the "Company" , a diversified life sciences company, today commented about the status of its Form 10-K for the year ended March 31, 2015 (the "Form 10-K" .
Tauriga Sciences Inc. Granted 7 Day Extension by OTC Markets to Maintain Listing on OTCQB Exchange
Marketwired - Wed Jul 29, 3:50PM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or the "Company" , a diversified life sciences company, today announced that is has been granted a 7 calendar day extension by OTC Markets to continue trading on the OTCQB exchange despite the Company's inability to file its Form 10-K for the year ended March 31, 2015 ("Form 10-K" with the Securities and Exchange Commission ("SEC" prior to 5:30 pm EDT today, July 29, 2015. If this extension had not been granted, Tauriga's common stock would have been moved to the OTC Pink Limited Information category at open of trading Thursday, July 30, 2015.
Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock
PR Newswire - Tue Jul 28, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or the "Company" , a diversified life sciences company, today announced that its stockholders approved an increase in the number of authorized shares of common stock of the Company from 1,000,000,000 to 2,500,000,000 at its Special Meeting of Stockholders held on July 27, 2015 at the Law Offices of Nixon Peabody LLP in Midtown Manhattan (the "Special Meeting" . At the Special Meeting, there were 480,655,929 shares of common stock represented either by proxy or in person of the 929,825,933 shares of common stock entitled to vote, constituting a quorum. Of those shares, there were 433,331,977, or 90.2%, that voted in favor of the proposal recommended by the Board of Directors. The remaining votes were cast either against or as abstentions regarding the proposal.
Tauriga Sciences Inc. Wholly Owned Subsidiary Pilus Energy LLC Executes Commercialization and Distribution Agreement with Singapore Based Naturo Energy Pte. Ltd.
PR Newswire - Tue Jul 21, 8:54AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company" , an internationally diversified life sciences company, today announced that its wholly owned subsidiary Pilus Energy LLC ("Pilus Energy" has executed a Commercialization and Distribution Agreement ("the Agreement" with Singapore based Naturo Energy Pte. Ltd. ("Naturo Energy" . The Agreement will be exclusive for the continent of Asia and focus on the commercialization of U.S. Patent # 8,354,267 Titled "Microbial Fuel Cell" which was granted to Bacterial Robotics, LLC ("Bacterial Robotics" on January 15, 2013. Recall that on January 28, 2014 Tauriga Sciences acquired 100% of the outstanding shares of Pilus Energy (inclusive of U.S. Patent # 8,354,267) from Bacterial Robotics (now known as Microbial Robotics). Naturo Energy has committed to Pilus Energy the following engagement activities: seek Research Collaboration with local universities, seek Commercial Collaboration with leading global providers of services and products for the water and wastewater industry, and seek Test-Bedding opportunities with local wastewater treatment plants.
Tauriga Sciences, Inc. to Complete the Increase of Authorized Shares Prior to Filing Fiscal Year 2015 Annual Report (Form 10K)
PR Newswire - Tue Jul 14, 2:03PM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company" , a diversified life sciences company, today announced that the Company has decided to complete the proposed increase in authorized shares of common stock from 1 billion to 2.5 billion as more fully described in the Preliminary Schedule 14A filed with the Securities and Exchange Commission prior to filing its Annual Report on Form 10-K for the fiscal year ended March 31, 2015 ("Form 10-K" . The Company anticipates that it will be filing and mailing the Definitive Schedule 14A with the location and time of the special shareholder meeting. The Company will proceed to file its Form 10-K shortly thereafter and, if so, will not be at any risk of being delisted from the OTCQB exchange from the delay of filing Form 10-K.
Tauriga Sciences Inc. Announces Strategic Plan to Divest Natural Wellness Business
PR Newswire - Mon Jul 13, 7:01AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that it intends to fully divest its natural wellness business within the next two months. The Company has entered into a Letter of Intent to sell the assets of its natural wellness business. As part of the proposed transaction, Dr. Stella Sung would run the natural wellness business under its new corporate ownership, and Lawrence A. May, M.D. would serve as Chief Medical Officer. Accordingly, Dr. Sung has resigned her position as Tauriga's Chairman & CEO effective July 9, 2015 and Dr. May has resigned his position as Tauriga's Chief Medical Officer effective July 10, 2015. Dr. Sung will continue to support Tauriga in the important role of Chairman of the Medical Advisory Board.
Tauriga Sciences, Inc. Appoints Mr. Seth M. Shaw to Positions of Chairman and Chief Executive Officer and Ms. Ghalia Lahlou as Interim Chief Financial Officer Effective Immediately
PR Newswire - Mon Jul 13, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company" , a diversified life sciences company, today announced the appointments of Mr. Seth M. Shaw as Chairman of the Board of Directors ("Chairman" and Chief Executive Officer ("CEO" and Ms. Ghalia Lahlou as Interim Chief Financial Officer ("Interim CFO" . Ms. Lahlou will maintain her current position as Corporate Secretary ("Secretary" as well. The outgoing CEO, Dr. Stella M. Sung will continue to support the Company in the important role of Chairman of the Medical Advisory Board.
UNXL: 1.87 (+0.69), LTBR: 0.95 (+0.04)
Tauriga Sciences Inc. to Showcase TopiCanna Cream and Other Natural Wellness Products at the 2015 Northern California Cannabis Cup
PR Newswire - Fri Jun 12, 9:49AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that the Company will have a booth at the Northern California Cannabis Cup to be held in San Francisco, California on June 20-21, 2015 (http://www.cannabiscup.com/norcal/). Tauriga's booth at the event will feature the Company's cannabidiol (CBD) products, TopiCanna cream and CannaCaviar soft gels, as well as Tauriga's natural wellness supplements. Tauriga will also be marketing Breathe eCig Corp.'s second generation e-cigarettes at its booth, under a revenue sharing arrangement.
Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD
PR Newswire - Tue Jun 02, 12:08PM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that it has officially extinguished all further obligations to Typenex Co-Investment, LLC ("Typenex" in exchange for a one-time cash payment of $230,000 USD. On January 16, 2015, the Company and Typenex entered into a Settlement Agreement (the "Settlement Agreement" as fully disclosed in a Current Report on Form 8-K filed with Securities and Exchange Commission on January 23, 2015. The Settlement Agreement was entered into between the Company and Typenex to settle litigation between the parties previously disclosed in the Company's Quarterly Report on Form 10-Q filed on November 19, 2014 regarding 70,080,714 shares of the Company's common stock, par value $0.001, Typenex believed it was due under a purported warrant issued in connection and arising from a convertible promissory note issued by the Company to Typenex on June 24, 2013.
Tauriga Sciences, Inc. to Present at Cannabis Investor Webcast
PR Newswire - Tue Jun 02, 7:30AM CDT
Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology will be presenting on the Cannabis Investor Webcast on Tuesday, June 4, 2015 at 12:00 pm EDT/9:00 am PDT.
Tauriga Sciences, Inc. Subsidiary Pilus Energy to Participate in 2015 World Environmental & Water Resources Congress
PR Newswire - Fri May 15, 7:30AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, is pleased to announce that its subsidiary Pilus Energy will be participating in the 2015 World Environmental & Water Resources Congress in Austin, TX May 17-21 at the JW Marriot (110 E. Second St. Austin, TX 78701). Pilus will be presenting at the Sunday poster session from 4:30 pm to midnight. The theme for this year is Floods, Droughts, and Ecosystems: Managing Our Resources Despite Growing Demands and Diminishing Funds.
Tauriga Sciences, Inc. and Cannabis Health Form "Foundational Partnership"
PR Newswire - Wed May 13, 7:15AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, announced today that it has formed a "Foundational Partnership" with Cannabis Health, an information based media company that focuses on the health and science of cannabis. Under this partnership agreement, Tauriga and its principals will provide Cannabis Health with medical and scientific content for Cannabis Health's print and electronic publication and dissemination. Cannabis Health will help increase exposure to Tauriga and its natural wellness products. Both companies will help each other market their shared vision of utilizing cannabis as a natural medicine.
SEC Compliance Featuring Products From Tauriga Sciences, Inc. at B. Riley & Co. Conference
PR Newswire - Mon May 11, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, announced today that its products will be featured at the SEC Compliance sponsor booth at this week's 16th Annual B. Riley & Co. Investor Conference on May 12th-14th at The Loews Hollywood Hotel in Los Angeles, California. B. Riley & Co.'s investment conference highlights over 250 publicly-traded companies and dozens of privately-held firms showcasing their stories to an expected audience of institutional investors, corporate clients, and high-net worth individuals.
Breathe eCig Corp. Announces Initial Purchase Order From Knoxville Based Retail & Distribution Partner
PR Newswire - Wed Apr 29, 9:13AM CDT
Breathe eCig Corp. (OTCQB: BVAP) ("Breathe" or "the Company" , electronic cigarette industry innovator and pioneer, has announced that it has received a purchase order for all of its remaining first generation product from Knoxville, Tennessee based distributor Ampa Group ("Ampa" . Ampa, inclusive of its affiliate companies, owns and operates over 30 retail locations, a hospitality portfolio and has a distribution alliance that reaches over 300 unique retailers in the East Tennessee region spanning from Johnson City to Chattanooga. Ampa has also provided the Company with a much larger purchase commitment for the Company's second generation products, including the CBD e-cigarette being co-developed with Tauriga (OTCQB:TAUG). The Company has been working diligently with its Hong Kong based manufacturer, The KMG Group ("KMG" , to ensure delivery of its proprietary second generation device by May 20, 2015. Once the Company is notified by KMG of the exact delivery date of its second generation product, it will notify shareholders via a press release.
Tauriga Sciences Inc. Reports Estimated Quarterly Revenue Growth Exceeding 60% and Provides Shareholder Update
PR Newswire - Thu Apr 23, 12:18PM CDT
Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or the "Company" , a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, has today pre-announced positive quarterly revenues for the first calendar quarter of 2015, which ended on March 31, 2015 (the Company's fourth fiscal quarter of 2015). The Company is pleased to disclose that estimated quarterly revenue growth, as compared to the previous quarter ending December 31, 2014, exceeded 60% and the estimated total quarterly sales are approximately $50,000 USD. These figures are unaudited, and the exact revenue number along with the full financial results of the Company for its fiscal year ended March 31, 2015 will be disclosed in the Company's upcoming Annual Report on Form 10-K.
Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part IX
Anthony Cataldo - at Seeking Alpha - Tue Apr 21, 12:43AM CDT
Tauriga Sciences, Inc. Obtains Determination From OTC Markets Concerning OTCQB Listing Requirements
Marketwired - Thu Oct 08, 7:01AM CDT
Tauriga Sciences, Inc. (OTC PINK: TAUG) or ("Tauriga" or the "Company"
, a diversified life sciences company focused on building its existing technologies and evaluating potential acquisition candidates, has today announced that the Company has been granted additional time to regain compliance with OTCQB listing requirements. Specifically Tauriga has been notified by OTC Markets that it has until close of business January 27, 2016 ("extended deadline" to fully comply with the listing requirements that govern fully reporting U.S. companies listed on the OTCQB. By that date, the Company must become current with its delinquent filings ("filings" , post a new OTCQB Certification via www.otciq.com, and close at or above $.01 per share for 30 consecutive days. Currently shares of Tauriga are listed on the OTC Pink Limited Information Tier until it regains compliance with the above requirements. Tauriga Sciences, Inc. Secures $180,000 USD in Non-Convertible Debt Financing From Singapore-Based Institutional Investor
Marketwired - Thu Oct 01, 10:45AM CDT
Tauriga Sciences, Inc. (OTC PINK: TAUG) or ("Tauriga" or the "Company"
, a diversified life sciences company focused on building its existing technologies and evaluating potential acquisition candidates, has today announced the completion of $180,000 USD in Non-Convertible debt financing from Singapore-based institutional investor ALTERNATIVE STRATEGY PARTNERS PTE. LTD. ("ASP" . The debt carries a fixed interest rate per annum of 11.50% ("the Designated Rate" payable in full by December 23, 2015 ("the Maturity Date" . Both parties have discussed the possibility of amending terms, if necessary, under the assumption that both parties mutually agree to such amendment. Tauriga Sciences Inc. Issues Shareholder Update on Status of Company and Future Strategic Plan
Marketwired - Fri Aug 14, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or the "Company"
, a diversified life sciences company, is providing its shareholders with a comprehensive update on the status of the Company as well as it strategic plan for the future. The Company's Board of Directors ("Board" has met multiple times over the past weeks to address several important issues. The Company will continually issue press releases to update shareholders whenever practicable. Tauriga Sciences, Inc. Appoints Mr. Thomas J. Graham as a Member of the Board of Directors
Marketwired - Wed Aug 05, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or the "Company"
, a diversified life sciences company, today announced the appointment of Mr. Thomas J. Graham as the fourth member of the Company's Board of Directors ("Board" . The appointment is effective immediately and Mr. Graham will qualify as an "independent" under the rules of the Securities and Exchange Commission. In the future, Mr. Graham may also be appointed to certain committees of Board. Tauriga Sciences Inc. Comments on the Status of Fiscal Year 2015 Form 10-K Filing
Marketwired - Fri Jul 31, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or the "Company"
, a diversified life sciences company, today commented about the status of its Form 10-K for the year ended March 31, 2015 (the "Form 10-K" . Tauriga Sciences Inc. Granted 7 Day Extension by OTC Markets to Maintain Listing on OTCQB Exchange
Marketwired - Wed Jul 29, 3:50PM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or the "Company"
, a diversified life sciences company, today announced that is has been granted a 7 calendar day extension by OTC Markets to continue trading on the OTCQB exchange despite the Company's inability to file its Form 10-K for the year ended March 31, 2015 ("Form 10-K" with the Securities and Exchange Commission ("SEC" prior to 5:30 pm EDT today, July 29, 2015. If this extension had not been granted, Tauriga's common stock would have been moved to the OTC Pink Limited Information category at open of trading Thursday, July 30, 2015. Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock
PR Newswire - Tue Jul 28, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or the "Company"
, a diversified life sciences company, today announced that its stockholders approved an increase in the number of authorized shares of common stock of the Company from 1,000,000,000 to 2,500,000,000 at its Special Meeting of Stockholders held on July 27, 2015 at the Law Offices of Nixon Peabody LLP in Midtown Manhattan (the "Special Meeting" . At the Special Meeting, there were 480,655,929 shares of common stock represented either by proxy or in person of the 929,825,933 shares of common stock entitled to vote, constituting a quorum. Of those shares, there were 433,331,977, or 90.2%, that voted in favor of the proposal recommended by the Board of Directors. The remaining votes were cast either against or as abstentions regarding the proposal. Tauriga Sciences Inc. Wholly Owned Subsidiary Pilus Energy LLC Executes Commercialization and Distribution Agreement with Singapore Based Naturo Energy Pte. Ltd.
PR Newswire - Tue Jul 21, 8:54AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"
, an internationally diversified life sciences company, today announced that its wholly owned subsidiary Pilus Energy LLC ("Pilus Energy" has executed a Commercialization and Distribution Agreement ("the Agreement" with Singapore based Naturo Energy Pte. Ltd. ("Naturo Energy" . The Agreement will be exclusive for the continent of Asia and focus on the commercialization of U.S. Patent # 8,354,267 Titled "Microbial Fuel Cell" which was granted to Bacterial Robotics, LLC ("Bacterial Robotics" on January 15, 2013. Recall that on January 28, 2014 Tauriga Sciences acquired 100% of the outstanding shares of Pilus Energy (inclusive of U.S. Patent # 8,354,267) from Bacterial Robotics (now known as Microbial Robotics). Naturo Energy has committed to Pilus Energy the following engagement activities: seek Research Collaboration with local universities, seek Commercial Collaboration with leading global providers of services and products for the water and wastewater industry, and seek Test-Bedding opportunities with local wastewater treatment plants. Tauriga Sciences, Inc. to Complete the Increase of Authorized Shares Prior to Filing Fiscal Year 2015 Annual Report (Form 10K)
PR Newswire - Tue Jul 14, 2:03PM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company, today announced that the Company has decided to complete the proposed increase in authorized shares of common stock from 1 billion to 2.5 billion as more fully described in the Preliminary Schedule 14A filed with the Securities and Exchange Commission prior to filing its Annual Report on Form 10-K for the fiscal year ended March 31, 2015 ("Form 10-K" . The Company anticipates that it will be filing and mailing the Definitive Schedule 14A with the location and time of the special shareholder meeting. The Company will proceed to file its Form 10-K shortly thereafter and, if so, will not be at any risk of being delisted from the OTCQB exchange from the delay of filing Form 10-K. Tauriga Sciences Inc. Announces Strategic Plan to Divest Natural Wellness Business
PR Newswire - Mon Jul 13, 7:01AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that it intends to fully divest its natural wellness business within the next two months. The Company has entered into a Letter of Intent to sell the assets of its natural wellness business. As part of the proposed transaction, Dr. Stella Sung would run the natural wellness business under its new corporate ownership, and Lawrence A. May, M.D. would serve as Chief Medical Officer. Accordingly, Dr. Sung has resigned her position as Tauriga's Chairman & CEO effective July 9, 2015 and Dr. May has resigned his position as Tauriga's Chief Medical Officer effective July 10, 2015. Dr. Sung will continue to support Tauriga in the important role of Chairman of the Medical Advisory Board. Tauriga Sciences, Inc. Appoints Mr. Seth M. Shaw to Positions of Chairman and Chief Executive Officer and Ms. Ghalia Lahlou as Interim Chief Financial Officer Effective Immediately
PR Newswire - Mon Jul 13, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company, today announced the appointments of Mr. Seth M. Shaw as Chairman of the Board of Directors ("Chairman" and Chief Executive Officer ("CEO" and Ms. Ghalia Lahlou as Interim Chief Financial Officer ("Interim CFO" . Ms. Lahlou will maintain her current position as Corporate Secretary ("Secretary" as well. The outgoing CEO, Dr. Stella M. Sung will continue to support the Company in the important role of Chairman of the Medical Advisory Board. UNXL: 1.87 (+0.69), LTBR: 0.95 (+0.04)
Tauriga Sciences Inc. to Showcase TopiCanna Cream and Other Natural Wellness Products at the 2015 Northern California Cannabis Cup
PR Newswire - Fri Jun 12, 9:49AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that the Company will have a booth at the Northern California Cannabis Cup to be held in San Francisco, California on June 20-21, 2015 (http://www.cannabiscup.com/norcal/). Tauriga's booth at the event will feature the Company's cannabidiol (CBD) products, TopiCanna cream and CannaCaviar soft gels, as well as Tauriga's natural wellness supplements. Tauriga will also be marketing Breathe eCig Corp.'s second generation e-cigarettes at its booth, under a revenue sharing arrangement. Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD
PR Newswire - Tue Jun 02, 12:08PM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that it has officially extinguished all further obligations to Typenex Co-Investment, LLC ("Typenex" in exchange for a one-time cash payment of $230,000 USD. On January 16, 2015, the Company and Typenex entered into a Settlement Agreement (the "Settlement Agreement" as fully disclosed in a Current Report on Form 8-K filed with Securities and Exchange Commission on January 23, 2015. The Settlement Agreement was entered into between the Company and Typenex to settle litigation between the parties previously disclosed in the Company's Quarterly Report on Form 10-Q filed on November 19, 2014 regarding 70,080,714 shares of the Company's common stock, par value $0.001, Typenex believed it was due under a purported warrant issued in connection and arising from a convertible promissory note issued by the Company to Typenex on June 24, 2013. Tauriga Sciences, Inc. to Present at Cannabis Investor Webcast
PR Newswire - Tue Jun 02, 7:30AM CDT
Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology will be presenting on the Cannabis Investor Webcast on Tuesday, June 4, 2015 at 12:00 pm EDT/9:00 am PDT. Tauriga Sciences, Inc. Subsidiary Pilus Energy to Participate in 2015 World Environmental & Water Resources Congress
PR Newswire - Fri May 15, 7:30AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, is pleased to announce that its subsidiary Pilus Energy will be participating in the 2015 World Environmental & Water Resources Congress in Austin, TX May 17-21 at the JW Marriot (110 E. Second St. Austin, TX 78701). Pilus will be presenting at the Sunday poster session from 4:30 pm to midnight. The theme for this year is Floods, Droughts, and Ecosystems: Managing Our Resources Despite Growing Demands and Diminishing Funds. Tauriga Sciences, Inc. and Cannabis Health Form "Foundational Partnership"
PR Newswire - Wed May 13, 7:15AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, announced today that it has formed a "Foundational Partnership" with Cannabis Health, an information based media company that focuses on the health and science of cannabis. Under this partnership agreement, Tauriga and its principals will provide Cannabis Health with medical and scientific content for Cannabis Health's print and electronic publication and dissemination. Cannabis Health will help increase exposure to Tauriga and its natural wellness products. Both companies will help each other market their shared vision of utilizing cannabis as a natural medicine. SEC Compliance Featuring Products From Tauriga Sciences, Inc. at B. Riley & Co. Conference
PR Newswire - Mon May 11, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, announced today that its products will be featured at the SEC Compliance sponsor booth at this week's 16th Annual B. Riley & Co. Investor Conference on May 12th-14th at The Loews Hollywood Hotel in Los Angeles, California. B. Riley & Co.'s investment conference highlights over 250 publicly-traded companies and dozens of privately-held firms showcasing their stories to an expected audience of institutional investors, corporate clients, and high-net worth individuals. Breathe eCig Corp. Announces Initial Purchase Order From Knoxville Based Retail & Distribution Partner
PR Newswire - Wed Apr 29, 9:13AM CDT
Breathe eCig Corp. (OTCQB: BVAP) ("Breathe" or "the Company"
, electronic cigarette industry innovator and pioneer, has announced that it has received a purchase order for all of its remaining first generation product from Knoxville, Tennessee based distributor Ampa Group ("Ampa" . Ampa, inclusive of its affiliate companies, owns and operates over 30 retail locations, a hospitality portfolio and has a distribution alliance that reaches over 300 unique retailers in the East Tennessee region spanning from Johnson City to Chattanooga. Ampa has also provided the Company with a much larger purchase commitment for the Company's second generation products, including the CBD e-cigarette being co-developed with Tauriga (OTCQB:TAUG). The Company has been working diligently with its Hong Kong based manufacturer, The KMG Group ("KMG" , to ensure delivery of its proprietary second generation device by May 20, 2015. Once the Company is notified by KMG of the exact delivery date of its second generation product, it will notify shareholders via a press release. Tauriga Sciences Inc. Reports Estimated Quarterly Revenue Growth Exceeding 60% and Provides Shareholder Update
PR Newswire - Thu Apr 23, 12:18PM CDT
Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or the "Company"
, a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, has today pre-announced positive quarterly revenues for the first calendar quarter of 2015, which ended on March 31, 2015 (the Company's fourth fiscal quarter of 2015). The Company is pleased to disclose that estimated quarterly revenue growth, as compared to the previous quarter ending December 31, 2014, exceeded 60% and the estimated total quarterly sales are approximately $50,000 USD. These figures are unaudited, and the exact revenue number along with the full financial results of the Company for its fiscal year ended March 31, 2015 will be disclosed in the Company's upcoming Annual Report on Form 10-K. Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part IX
Anthony Cataldo - at Seeking Alpha - Tue Apr 21, 12:43AM CDT
